April 06, 2015; 84 (14 Supplement) April 22, 2015
Study of beta cells and neurons indicate incretin analogs as potential therapeutics for Friedreich’s ataxia. (S32.005)
Massimo Pandolfo, Mariana Igoillo-Esteve, Amélie Hu, Ewa Gurgul-Convey, Laila Romagueira Bichara Dos Santos, Jonas Jean-Christophe, Decio Eizirik, Miriam Cnop
First published April 8, 2015,
Massimo Pandolfo
4Neurology Université Libre De Bruxelles Brussels Belgium
Mariana Igoillo-Esteve
5ULB Center for Diabetes Research Université Libre de Bruxelles Brussels Belgium
Amélie Hu
3Laboratory of Experimental Neurology Université Libre De Bruxelles Brussels Belgium
Ewa Gurgul-Convey
1Institute of Clinical Biochemistry Hannover Medical School Hannover Germany
Laila Romagueira Bichara Dos Santos
2Institut de recherche expérimentale et clinique, Pôle d’endocrinologie, diabète et nutrition Université Catholique de Louvain Brussels Belgium
Jonas Jean-Christophe
2Institut de recherche expérimentale et clinique, Pôle d’endocrinologie, diabète et nutrition Université Catholique de Louvain Brussels Belgium
Decio Eizirik
5ULB Center for Diabetes Research Université Libre de Bruxelles Brussels Belgium
Miriam Cnop
5ULB Center for Diabetes Research Université Libre de Bruxelles Brussels Belgium
Study of beta cells and neurons indicate incretin analogs as potential therapeutics for Friedreich’s ataxia. (S32.005)
Massimo Pandolfo, Mariana Igoillo-Esteve, Amélie Hu, Ewa Gurgul-Convey, Laila Romagueira Bichara Dos Santos, Jonas Jean-Christophe, Decio Eizirik, Miriam Cnop
Neurology Apr 2015, 84 (14 Supplement) S32.005;
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 84 no. 14 Supplement S32.005
Print ISSN:
Online ISSN:
History:
- First Published April 8, 2015.
Copyright & Usage:
Copyright © 2015 by AAN Enterprises, Inc.
Author Disclosures
- Massimo Pandolfo4,
- Mariana Igoillo-Esteve5,
- Amélie Hu3,
- Ewa Gurgul-Convey1,
- Laila Romagueira Bichara Dos Santos2,
- Jonas Jean-Christophe2,
- Decio Eizirik5 and
- Miriam Cnop5
- Massimo Pandolfo4,
- Mariana Igoillo-Esteve5,
- Amélie Hu3,
- Ewa Gurgul-Convey1,
- Laila Romagueira Bichara Dos Santos2,
- Jonas Jean-Christophe2,
- Decio Eizirik5 and
- Miriam Cnop5
- 1Institute of Clinical Biochemistry Hannover Medical School Hannover Germany
- 2Institut de recherche expérimentale et clinique, Pôle d’endocrinologie, diabète et nutrition Université Catholique de Louvain Brussels Belgium
- 3Laboratory of Experimental Neurology Université Libre De Bruxelles Brussels Belgium
- 4Neurology Université Libre De Bruxelles Brussels Belgium
- 5ULB Center for Diabetes Research Université Libre de Bruxelles Brussels Belgium
Article usage
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.